Hey bros, can someone that understand pharma companies a bit more help me with this. NEUs recent presentation shows they also received a 10mil upfront payment in 2018. Only at the end of 2021 did the share price really start climbing quickly. (I’m guessing this is because they commercialised and started selling their drug? Can someone that knows pharma companies or was around during the last few years of NEU explain what phase they were up to when we were ect.
Appreciate any thoughts, I’m very good at valuing mining companies but struggling as med companies are valued all over the place on the asx tbh
Ann: Dimerix Receives Initial Upfront Payment from Advanz Pharma, page-101
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.5¢ |
Change
-0.005(1.06%) |
Mkt cap ! $255.8M | |||
| Open | High | Low | Value | Volume |
| 47.0¢ | 48.5¢ | 46.5¢ | $1.514M | 3.204M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 121059 | 46.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.5¢ | 106197 | 4 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |